IsoRay ships first GliaSite system; CARMAT gets OK in France for trial with artificial heart;

> IsoRay has shipped its first GliaSite radiation therapy system. The GliaSite radiation therapy system is a balloon catheter device used in the treatment of brain cancer. IsoRay release

> CARMAT has been given the go‐ahead from the Patient Protection Committee for the first clinical trial in France involving the implantation of the total artificial heart in patients. CARMAT release

> GE Healthcare ($GE) announced an additional $300 million investment in low-dose technologies and unveiled radiation-dose management offerings at RSNA 2011. GE release

> Randox Food Diagnostics' Anthelmintics testing platform (EV3770) has been released. This multi-analyte testing array is used in conjunction with the patented Randox Biochip Array Technology and Evidence Investigator analyzer. The extensive test menu includes Avermectins, Benzimidazoles, Amino-benzimidazoles, Levamisole, Thiabendazole, Moxidectin and Triclabendazole. Randox release

> Intelerad Medical Systems has unveiled a new mobile-friendly interface for the InteleConnect web portal--a brandable, browser-based solution for communicating radiology results to referring physicians. Intelerad release

And Finally... Researchers are offering hope to victims of serious facial injuries through the combination of conventional medical imaging and the same 3-D modeling techniques used in Hollywood. Results of a new study on human face transplantation have been presented at the annual meeting of the Radiological Society of North America. RSNA release

Suggested Articles

The FDA has authorized its first COVID-19 antibody test for use in doctors' offices, urgent care centers and emergency rooms.

The clinical testing giant LabCorp will now begin rolling out a blood test for lung cancer developed by Resolution Bioscience.

Cognoa aims to equip pediatricians with an AI-powered app that can spot the signs of autism, allowing them to diagnose in the doctor's office.